Patient Inclusive Advisory Boards
Patient advisory boards are fundamental activities for the industry to better understand the lived experience of patients and caregivers. Advisory boards offer patients and caregivers the opportunity to provide insights and guidance on various aspects of drug development and healthcare delivery. These boards ensure that the perspectives and experiences of patients are integrated into the decision-making process, from early-stage research to clinical trials and through commercialization. By incorporating firsthand patient feedback, advisory boards help shape the relevance and applicability of drug development programs by ensuring they address real-world concerns, preferences, and unmet needs.
However, if your patient advisory boards are not inclusive and representative of the makeup of the patient community, you are not getting the full picture of unmet needs and insights. By incorporating a patient-inclusive approach to your advisory boards, you can ensure you are getting a breadth of insights from a more representational sample of the patient community including those historically excluded from clinical research.
A patient inclusive approach benefits both industry and patient community objectives by ensuring everyone’s voice is heard, focusing on collaboration, building trust, and fostering stronger relationships with the patient and caregiver community.
Firak Consulting Group is available to support your organization’s advisory boards to make them patient-inclusive with:
Board Formation and Facilitation: Planning and execution of advisory boards that include diverse lived experiences, ensuring that these activities are inclusive and effectively reflect the patient population.
Actionable Outputs: Organize and analyze advisory board insights through structured feedback mechanisms to deliver actionable outcomes that contribute to drug development decision-making.